- 现金
- 55 元
- 精华
- 0
- 帖子
- 42
- 注册时间
- 2016-6-14
- 最后登录
- 2018-3-10
|
本帖最后由 Vincent808 于 2016-11-11 13:02 编辑
Gilead has also established licensing agreements with 19 generic drug manufacturers in India, South Africa and China, as well as the Medicines Patent Pool, granting them rights to produce and sell high-quality, low-cost generic versions of Gilead HBV medicines in 112 developing countries. Vemlidy is already an integrated component of the company’s generic licensing agreements, and with FDA approval, manufacturing partners may begin production and distribution of a generic version of this medicine.
看了这段 看来 中国上市也不远了。。但是估计不会便宜,美国全世界最贵。。。 国内的战友 也会尽快用上新药的。加油。 |
|